Bivalirudin Injection, Powder, Lyophilized, For Solution
Product Images NDC 16729-275

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bivalirudin (NDC 16729-275). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (Bivalirudin Carton Label)

This is a description of a medical product that is used for intravenous injection. The product is called Bivalirudin and can only be used once. The package includes the dosage strength of 25 T. The identification code NDC 16729-275-67 is also provided.*

FDA Label Image

Container Label (Bivalirudin Container Label)

This vial contains 250 mg of bivalirudin with Mannitol and Sodium Hydroxide for injection. Each mL contains 50 mg of bivalirudin. It should be stored between 20° to 25°C and not permitted to vary between 15° to 30°C. It is intended for Intravenous use only and is a single-dose. Please refer to the Batch coding and Mig. Lc. No. for details. Made by Intas Pharmaceuticals Ltd. in India for Accord Healthcare Inc.*

FDA Label Image

Bivalirudin Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.